ENTO logo

Entero Therapeutics (ENTO) Total Assets

Annual Total Assets

$6.88 M
+$1.44 M+26.54%

December 31, 2023


Summary


Performance

ENTO Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTObalance sheetmetrics:

Quarterly Total Assets

$85.82 M
-$466.90 K-0.54%

September 1, 2024


Summary


Performance

ENTO Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTObalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

ENTO Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.5%+1146.8%
3 y3 years-46.7%+1450.8%
5 y5 years-7.8%+809.5%

ENTO Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-41.6%+26.5%-5.8%+2085.2%
5 y5-year-46.7%+26.5%-5.8%+2085.2%
alltimeall time-46.7%+26.5%-5.8%+2085.2%

Entero Therapeutics Total Assets History

DateAnnualQuarterly
Sep 2024
-
$85.82 M(-0.5%)
Jun 2024
-
$86.29 M(-5.3%)
Mar 2024
-
$91.13 M(+1224.0%)
Dec 2023
$6.88 M(+26.5%)
$6.88 M(+16.1%)
Sep 2023
-
$5.93 M(+37.0%)
Jun 2023
-
$4.33 M(-21.8%)
Mar 2023
-
$5.53 M(+1.7%)
Dec 2022
$5.44 M(-53.9%)
-
Dec 2022
-
$5.44 M(+17.1%)
Sep 2022
-
$4.65 M(+18.3%)
Jun 2022
-
$3.93 M(-55.5%)
Mar 2022
-
$8.83 M(-25.1%)
Dec 2021
$11.79 M(-8.8%)
$11.79 M(-5.1%)
Sep 2021
-
$12.42 M(-9.8%)
Jun 2021
-
$13.78 M(-23.4%)
Mar 2021
-
$17.98 M(+39.1%)
Dec 2020
$12.92 M
$12.92 M(-22.7%)
Sep 2020
-
$16.72 M(+143.7%)
Jun 2020
-
$6.86 M(-16.2%)
DateAnnualQuarterly
Mar 2020
-
$8.18 M(-8.1%)
Dec 2019
$8.90 M(+19.2%)
$8.90 M(-5.6%)
Sep 2019
-
$9.44 M(-1.8%)
Jun 2019
-
$9.61 M(+7.3%)
Mar 2019
-
$8.96 M(+19.9%)
Dec 2018
$7.47 M(+36.3%)
$7.47 M(-12.9%)
Sep 2018
-
$8.58 M(-26.9%)
Jun 2018
-
$11.74 M(+123.7%)
Mar 2018
-
$5.25 M(-4.2%)
Dec 2017
$5.48 M(-18.9%)
$5.48 M(-19.8%)
Sep 2017
-
$6.84 M(-22.0%)
Jun 2017
-
$8.76 M(+61.6%)
Mar 2017
-
$5.42 M(-19.7%)
Dec 2016
$6.75 M(+1.0%)
$6.75 M(+20.9%)
Sep 2016
-
$5.59 M(-15.1%)
Jun 2016
-
$6.58 M(+4.3%)
Mar 2016
-
$6.31 M(-5.6%)
Dec 2015
$6.69 M(+1.7%)
$6.69 M
Dec 2014
$6.58 M
-

FAQ

  • What is Entero Therapeutics annual total assets?
  • What is the all time high annual total assets for Entero Therapeutics?
  • What is Entero Therapeutics annual total assets year-on-year change?
  • What is Entero Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Entero Therapeutics?
  • What is Entero Therapeutics quarterly total assets year-on-year change?

What is Entero Therapeutics annual total assets?

The current annual total assets of ENTO is $6.88 M

What is the all time high annual total assets for Entero Therapeutics?

Entero Therapeutics all-time high annual total assets is $12.92 M

What is Entero Therapeutics annual total assets year-on-year change?

Over the past year, ENTO annual total assets has changed by +$1.44 M (+26.54%)

What is Entero Therapeutics quarterly total assets?

The current quarterly total assets of ENTO is $85.82 M

What is the all time high quarterly total assets for Entero Therapeutics?

Entero Therapeutics all-time high quarterly total assets is $91.13 M

What is Entero Therapeutics quarterly total assets year-on-year change?

Over the past year, ENTO quarterly total assets has changed by +$78.94 M (+1146.81%)